Immuron hails record monthly sales of Travelan

Immuron Ltd (NASDAQ:IMRN, ASX:IMC) CEO Steve Lydeamore speaks with Proactive following news the company has achieved record monthly sales of its over-the-counter gastrointestinal supplement Travelan® https://www.proactiveinvestors.com/companies/news/1026469/immuron-hails-record-monthly-sales-of-travelan-1026469.html

This category is empty! Please try another category or use our search function to find what you are looking for. If you require further assistance please contact us.